TP53 mutation is associated with a poor clinical outcome for non-small cell lung cancer: Evidence from a meta-analysis

A number of studies have examined the association between tumor protein 53 (TP53) mutations and the clinical outcome in patients with non-small-cell lung cancer (NSCLC), although these have yielded conflicting results. In the present study, electronic databases updated to September 2015 were searche...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Jincui, Zhou, Yanbin, Huang, Lixia, Ou, Weijun, Wu, Jian, Li, Shaoli, Xu, Junwen, Feng, Jinlun, Liu, Baomo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228103/
https://www.ncbi.nlm.nih.gov/pubmed/28101350
http://dx.doi.org/10.3892/mco.2016.1057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228103/
https://www.ncbi.nlm.nih.gov/pubmed/28101350
http://dx.doi.org/10.3892/mco.2016.1057

Ejemplares similares